Evidence map›Paper›PMID 40610520›Full record

ArticleScientific reports2025

Atopic dermatitis-related anti-inflammatory in vitro effects of a plant extract mixture.

Nina Heinemann, Franziska Rademacher, Henning Vollert, Regine Gläser, Jürgen Harder

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. GC-Ms, UHPLC-MS/MSChemistry & biodiversity · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nina HeinemannDepartment of Dermatology Quincke Research Center, Kiel University, Rosalind-Franklin Str. 9, Kiel, 24105, Germany.
Franziska RademacherDepartment of Dermatology Quincke Research Center, Kiel University, Rosalind-Franklin Str. 9, Kiel, 24105, Germany.
Henning VollertBioactive Food GmbH, Bad Segeberg, Germany.
Regine GläserDepartment of Dermatology Quincke Research Center, Kiel University, Rosalind-Franklin Str. 9, Kiel, 24105, Germany.
Jürgen HarderDepartment of Dermatology Quincke Research Center, Kiel University, Rosalind-Franklin Str. 9, Kiel, 24105, Germany. jharder@dermatology.uni-kiel.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chronic inflammatory skin disease atopic dermatitis (AD) is characterized by barrier defects, inflammation and microbial dysbiosis with a high prevalence of Staphylococcus (S.) aureus. Previously, we reported that a plant extract mixture consisting of curly kale, green tea and apple had beneficial effects on AD. Herein we further investigated the underlying promising effects exerted by the plant extract. The extract exhibited direct antimicrobial activity against S. aureus and reduced the number of extra- and intracellular S. aureus in keratinocytes. Gene expression analyses and luciferase reporter assays in 2D and 3D AD-like skin models showed activation of the aryl hydrocarbon receptor (AhR) by the plant extract. Knockdown experiments with siRNA revealed an AhR-dependent induction of the skin barrier molecule filaggrin by the plant extract in the AD skin model. Moreover, the plant extract demonstrated antioxidative properties by reduction of intracellular reactive oxygen species and induction of the antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1). In conclusion, the antioxidant and antibacterial effects of the plant extract in combination with the AhR activation may be promising for the topical treatment of AD. Further research has to uncover the full potential of plant extracts for the treatment of AD and other inflammatory diseases.

Indexed as

Anti-Inflammatory AgentsDermatitis, AtopicPlant ExtractsAnti-Bacterial AgentsAntioxidantsFilaggrin ProteinsHumansKeratinocytesNAD(P)H Dehydrogenase (Quinone)Reactive Oxygen SpeciesReceptors, Aryl HydrocarbonStaphylococcus aureusAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsFilaggrin ProteinsFLG protein, humanNAD(P)H Dehydrogenase (Quinone)NQO1 protein, humanPlant ExtractsReactive Oxygen SpeciesReceptors, Aryl HydrocarbonAntioxidantAryl hydrocarbon receptorAtopic dermatitisPlant extract mixtureS. aureusSkin inflammation

Identifiers

PMID40610520
PMCPMC12229520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.